| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2001 | CN1308521A Novel formulation containing paroxetine |
| 08/15/2001 | CN1308520A Controlled release oral tablet having a unitary core |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/15/2001 | CN1308078A Camptothecin derivative and its preparation |
| 08/15/2001 | CN1308073A Partially synthetic seco-taxinane with antineoplastic activity |
| 08/15/2001 | CN1308072A Partially synthetic taxinane with antineoplastic activity |
| 08/15/2001 | CN1308071A Bicyclic DNA gyrase inhibitor |
| 08/15/2001 | CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite |
| 08/15/2001 | CN1308067A Preparation method of methylol hydantoin composite with low content of free formaldehyde |
| 08/15/2001 | CN1308066A Preparation of chiral succinic acid derivative |
| 08/15/2001 | CN1308059A Colchicine derivative and is treatment use |
| 08/15/2001 | CN1307904A Near infrared ray irradiation method for cosmetics and its application |
| 08/15/2001 | CN1307901A Treating synergist composite and its usage |
| 08/15/2001 | CN1307894A Plaster for treating hyperosteogeny and arthrosis |
| 08/15/2001 | CN1307883A Chinese medicine for treating lymph tuberculosis |
| 08/15/2001 | CN1307877A Plaster for cold |
| 08/15/2001 | CN1307873A Coated Gongyanping tablet in special shape and its making process |
| 08/15/2001 | CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage |
| 08/15/2001 | CN1307869A Depression treating medicine |
| 08/15/2001 | CN1307868A Bactericidal medicine |
| 08/15/2001 | CN1307867A Mizoribine tablet with improved color |
| 08/15/2001 | CN1307866A Production process of polymerized micelle with injected medicine and polymerized micelle composite |
| 08/15/2001 | CN1069650C Method for separation and purification of lentinan |
| 08/15/2001 | CN1069647C Compound with broad-spectrum antibacterial action |
| 08/15/2001 | CN1069643C Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 08/15/2001 | CN1069640C Adhesion receptor antagonists |
| 08/15/2001 | CN1069635C Novel phenylalkylaminoalcohol carbamates and process for prepn. of same |
| 08/15/2001 | CN1069544C Thebaica giving-up vaccinum for man |
| 08/15/2001 | CN1069523C Application of alginic polysaccharide sulfate in preparation of medicine for treating renal failure |
| 08/15/2001 | CN1069522C Transdermal presentation of nitroglycerin for preventing undesired uterine contraction |
| 08/15/2001 | CN1069521C Improvement of auxiliary material containing chlorohaxanpyridine acetate |
| 08/15/2001 | CN1069519C Radix aconiti kunsezoffil nail element soft capsule and production method thereof |
| 08/15/2001 | CN1069518C Oral medicine for reducing cholesterol |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | USRE37330 Glibenclamide-metformin combination for the treatment of diabetes mellitus of type II |
| 08/14/2001 | US6274768 Acridin derivatives |
| 08/14/2001 | US6274757 Neuromuscular relaxants |
| 08/14/2001 | US6274751 Fatty ester |
| 08/14/2001 | US6274740 Dissolving crystal form in solvent; drying |
| 08/14/2001 | US6274736 Chromatographic enantiomer separation of lactones |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274716 Combinatorial library of moenomycin analogs and methods of producing same |
| 08/14/2001 | US6274715 Semisynthetic macrolides, useful in bacterial infections treatment and prevention, has less potential for developing resistance, improved or modified profiles of desired gram-negative activity |
| 08/14/2001 | US6274708 Mouse interleukin-11 receptor |
| 08/14/2001 | US6274636 Method for treating a tic disorder |
| 08/14/2001 | US6274635 Antitumor agents |
| 08/14/2001 | US6274630 Administering polyamine |
| 08/14/2001 | US6274629 Use for 1,3-propanediol derivatives |
| 08/14/2001 | US6274627 Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor |
| 08/14/2001 | US6274626 Administering a composition of pheniramine maleate and povidone dropwise into the eye to reduce redness, dryness, and itching |
| 08/14/2001 | US6274624 Antiproliferative and neurotrophic molecules |
| 08/14/2001 | US6274623 Neuromuscular relaxants |
| 08/14/2001 | US6274622 Method of treating diabetic ophthalmopathy |
| 08/14/2001 | US6274621 Ginkgolides for inhibition of membrane expression of benzodiazepine receptors |
| 08/14/2001 | US6274619 Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274617 Heterocyclic ester and amide hair growth compositions and uses |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274615 Administering melatonin to inhibit or reverse the formation of fibrils associated with alzheimer's disease |
| 08/14/2001 | US6274612 Administering an amino acid protocol intravenously |
| 08/14/2001 | US6274611 Methods and compositions for inhibition of viral replication |
| 08/14/2001 | US6274609 4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1 -benzopyran or its hydrate and a surfactant |
| 08/14/2001 | US6274607 N-linked ureas and carbamates of heterocyclic thioesters |
| 08/14/2001 | US6274605 Administering an insulin sensitivity enhancer with an angiotensin converting enzyme inhibitor to reduce side effects to a diabetic patient |
| 08/14/2001 | US6274604 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 08/14/2001 | US6274603 Administering probucol or an analog to treat alzheimer's disease |
| 08/14/2001 | US6274602 Administering compostitions such as 3,3-dimethyl-1-((2s)-2-(5-(3-pyridyl) pentanoyl)-1-pyrrolidine)-1, 2-pentanedione to treat alopecia or promoting hair growth in animals |
| 08/14/2001 | US6274601 Methods of inhibiting ulcerative mucositis |
| 08/14/2001 | US6274599 Cisapride extended release |
| 08/14/2001 | US6274598 Methods for treating antibiotic-resistant infections |
| 08/14/2001 | US6274597 Method of enhancing lysosomal α-Galactosidase A |
| 08/14/2001 | US6274596 Benzoquinoline derivatives useful as antibacterial agents |
| 08/14/2001 | US6274595 Compositions for treating infection using optically pure (S)-lomefloxacin |
| 08/14/2001 | US6274594 Isoquinoline derivatives and their therapeutical use |
| 08/14/2001 | US6274593 Treating psychological disorders, schizophrenia, and parkinson*s disease |
| 08/14/2001 | US6274591 Administering enterically coated derivative to treat gastrointestinal disorders; side effect reduction |
| 08/14/2001 | US6274590 Administering 3,4-diarylthiophene derivative to treat eczema, burns, psoriasis, and dermatitis |
| 08/14/2001 | US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274584 Peptide derivatives; bioavailability; enzyme resistance; milk and wool production |
| 08/14/2001 | US6274583 Alpha 1a adrenergic receptor antagonists |
| 08/14/2001 | US6274582 Reduction of visceral fat |
| 08/14/2001 | US6274581 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 08/14/2001 | US6274580 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus |
| 08/14/2001 | US6274579 Pharmaceutically active morpholinol |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274575 Isolation of clavulanic acid from fermentation broth by ultrafiltration |
| 08/14/2001 | US6274574 Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products |
| 08/14/2001 | US6274573 Method of treatment for uterine leiomyoma |
| 08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 08/14/2001 | US6274571 Agent for preventing and curing fatty liver and method for curing thereof |
| 08/14/2001 | US6274568 Acylated n-mannosamine |
| 08/14/2001 | US6274567 Orally administering high amylose starch |
| 08/14/2001 | US6274566 Methods for treating mammals with modified alginates and pectins |
| 08/14/2001 | US6274563 Administering as antidiabetic agent |
| 08/14/2001 | US6274562 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 08/14/2001 | US6274559 Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274555 Composition and method for topical animal medication |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |